Sanofi India Limited (SANOFI.NS)

INR 6082.6

(-0.65%)

Operating Expenses Summary of Sanofi India Limited

  • Sanofi India Limited's latest annual operating expenses in 2023 was 4.13 Billion INR , down -48.17% from previous year.
  • Sanofi India Limited's latest quarterly operating expenses in 2024 Q2 was 665 Million INR , down -40.99% from previous quarter.
  • Sanofi India Limited reported a annual operating expenses of 9.18 Billion INR in annual operating expenses 2022, down -0.43% from previous year.
  • Sanofi India Limited reported a annual operating expenses of 9.22 Billion INR in annual operating expenses 2021, down -6.06% from previous year.
  • Sanofi India Limited reported a quarterly operating expenses of 665 Million INR for 2024 Q2, down -40.99% from previous quarter.
  • Sanofi India Limited reported a quarterly operating expenses of 2.11 Billion INR for 2023 Q1, down -9.49% from previous quarter.

Annual Operating Expenses Chart of Sanofi India Limited (2023 - 2004)

Historical Annual Operating Expenses of Sanofi India Limited (2023 - 2004)

Year Operating Expenses Operating Expenses Growth
2023 4.13 Billion INR -48.17%
2022 9.18 Billion INR -0.43%
2021 9.22 Billion INR -6.06%
2020 9.81 Billion INR -10.7%
2019 10.99 Billion INR 2.37%
2018 10.73 Billion INR 7.18%
2017 10.01 Billion INR 14.83%
2016 8.72 Billion INR 7.25%
2015 8.13 Billion INR 9.78%
2014 7.4 Billion INR 9.91%
2013 6.74 Billion INR 10.8%
2012 6.08 Billion INR 86.16%
2011 3.26 Billion INR 6.78%
2010 3.06 Billion INR 22.1%
2009 2.5 Billion INR 19.35%
2008 2.1 Billion INR -7.88%
2007 2.27 Billion INR 11.36%
2006 2.04 Billion INR 4.63%
2005 1.95 Billion INR 5.62%
2004 1.85 Billion INR 0.0%

Peer Operating Expenses Comparison of Sanofi India Limited

Name Operating Expenses Operating Expenses Difference
Abbott India Limited 5.98 Billion INR 30.975%
Cipla Limited 59.21 Billion INR 93.022%
Gland Pharma Limited 14.65 Billion INR 71.807%
GlaxoSmithKline Pharmaceuticals Limited 4.35 Billion INR 5.172%
Kopran Limited 1.41 Billion INR -191.85%
Marksans Pharma Limited 3.28 Billion INR -25.614%
NGL Fine-Chem Limited 1.75 Billion INR -136.081%
Pfizer Limited 4.33 Billion INR 4.731%
SMS Pharmaceuticals Limited 769.2 Million INR -437.177%
TTK Healthcare Limited 3.72 Billion INR -11.035%